NewsPronto

 
The Times


.

ACN Newswire

Read more press releases from ACN Newswire here

Eisai to Present Data on Oncology Pipeline and Products at ASCO Annual Meeting

  • Written by ACN Newswire

image

TOKYO, May 20, 2021 - (JCN Newswire) - Eisai Co., Ltd. announced today that the latest data regarding its oncology pipeline and products including in-house discovered lenvatinib mesylate (multikinase inhibitor, product name: LENVIMA, "lenvatinib") and eribulin mesylate (halichondrin class microtubule dynamics inhibitor, product name: HALAVEN,...

Read more: Eisai to Present Data on Oncology Pipeline and Products at ASCO Annual Meeting